Drugs / Zuretinol Acetate
Zuretinol Acetate
Trials 5
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 14 trials | ||||||
| Phase 1 | NCT01543906 | Feb 2012 → Jul 2014 | retinitis pigmentosa | QLT Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01521793 | Jan 2012 → May 2014 | Leber congenital amaurosis, retinitis pigmentosa | QLT Inc. | Completed | No outcome recorded |
| Phase 1 | NCT01014052 | Nov 2009 → Aug 2012 | Leber congenital amaurosis, retinitis pigmentosa | QLT Inc. | Completed | No outcome recorded |
| Phase 1 | NCT00765427 | Sep 2008 → Mar 2009 | — | QLT Inc. | Completed | No outcome recorded |
| Phase 21 trial | ||||||
| Phase 2 | NCT01999764 | Nov 2013 → Jun 2014 | night blindness | QLT Inc. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2/3 | NCT04311112 Comparator | Dec 2020 → Feb 2023 | retinal disorder | Retinagenix Holdings | Withdrawn | No outcome recorded |
News releases announcing trial results or a regulatory action · 4
All press releases naming this drug 5 releases
Evidence & citations 11 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Zuretinol Acetate | “Safety and Efficacy of Zuretinol Acetate in Subjects With Inherited Retinal Disease” NCT04311112 ↗ |
| Known as | 9-cis-retinal acetate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297637 ↗ |
| Known as | 9-cis-retinyl acetate | “with oral QLT091001 (synthetic 9-cis-retinyl acetate) in these patients.” PMID 25030840 ↗ Jul 2014 |
| Known as | 9-cis-vitamin a acetate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297637 ↗ |
| Known as | 9-cis-vitamin a1 acetate | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297637 ↗ |
| Known as | Acetate de zuretinol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297637 ↗ |
| Known as | Acetato de zuretinol | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297637 ↗ |
| Known as | QLT091001 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01999764 ↗ |
| Action | Restore | “We aimed to assess replacement of the missing chromophore 11-cis retinal with oral QLT091001” PMID 25030840 ↗ Jul 2014 |
| Modality | Small molecule | — CHEMBL4297637 ↗ |
| Route | Oral | “oral QLT091001 administered once daily for 7 days” NCT01014052 ↗ |